155 related articles for article (PubMed ID: 21277007)
1. Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism.
Resh M; Mahmoodi BK; Navis GJ; Veeger NJ; Lijfering WM
Thromb Res; 2011 May; 127(5):395-9. PubMed ID: 21277007
[TBL] [Abstract][Full Text] [Related]
2. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
Mahmoodi BK; ten Kate MK; Waanders F; Veeger NJ; Brouwer JL; Vogt L; Navis G; van der Meer J
Circulation; 2008 Jan; 117(2):224-30. PubMed ID: 18158362
[TBL] [Abstract][Full Text] [Related]
3. Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?
Lacut K; Le Gal G; Abalain JH; Mottier D; Oger E
Thromb Res; 2008; 122(3):314-9. PubMed ID: 18048086
[TBL] [Abstract][Full Text] [Related]
4. Dose-related effect of statins in venous thrombosis risk reduction.
Khemasuwan D; Chae YK; Gupta S; Carpio A; Yun JH; Neagu S; Lucca AB; Valsecchi ME; Mora JI
Am J Med; 2011 Sep; 124(9):852-9. PubMed ID: 21783169
[TBL] [Abstract][Full Text] [Related]
5. Adherence to statins is associated with reduced incidence of idiopathic venous thromboembolism: real-life data from a large healthcare maintenance organisation.
Rabinowich L; Steinvil A; Leshem-Rubinow E; Berliner S; Zeltser D; Rogowski O; Shalev V; Raz R; Chodick G
Heart; 2012 Dec; 98(24):1817-21. PubMed ID: 23038788
[TBL] [Abstract][Full Text] [Related]
6. Lipid lowering drugs and the risk of recurrent venous thromboembolism.
Delluc A; Tromeur C; Le Moigne E; Nowak E; Mottier D; Le Gal G; Lacut K
Thromb Res; 2012 Dec; 130(6):859-63. PubMed ID: 22939687
[TBL] [Abstract][Full Text] [Related]
7. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.
Pai M; Evans NS; Shah SJ; Green D; Cook D; Crowther MA
Thromb Res; 2011 Nov; 128(5):422-30. PubMed ID: 21641019
[TBL] [Abstract][Full Text] [Related]
8. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
9. Statins decrease the occurrence of venous thromboembolism in patients with cancer.
Khemasuwan D; Divietro ML; Tangdhanakanond K; Pomerantz SC; Eiger G
Am J Med; 2010 Jan; 123(1):60-5. PubMed ID: 20102993
[TBL] [Abstract][Full Text] [Related]
10. Statin use and the prevention of venous thromboembolism: a meta-analysis.
Agarwal V; Phung OJ; Tongbram V; Bhardwaj A; Coleman CI
Int J Clin Pract; 2010 Sep; 64(10):1375-83. PubMed ID: 20716146
[TBL] [Abstract][Full Text] [Related]
11. Statins and cancer risk.
Karp I; Behlouli H; Lelorier J; Pilote L
Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.
Holst AG; Jensen G; Prescott E
Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252
[TBL] [Abstract][Full Text] [Related]
13. [Statins can maybe reduce the risk of venous thromboembolism].
Toft-Petersen AP; Thomsen RW; Schmidt EB; Larsen TB
Ugeskr Laeger; 2011 May; 173(22):1558-63. PubMed ID: 21627898
[TBL] [Abstract][Full Text] [Related]
14. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
15. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome.
Welten GM; Chonchol M; Schouten O; Hoeks S; Bax JJ; van Domburg RT; van Sambeek M; Poldermans D
Nephrol Dial Transplant; 2008 Dec; 23(12):3867-73. PubMed ID: 18628367
[TBL] [Abstract][Full Text] [Related]
16. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study.
Lötsch F; Königsbrügge O; Posch F; Zielinski C; Pabinger I; Ay C
Thromb Res; 2014 Nov; 134(5):1008-13. PubMed ID: 25234407
[TBL] [Abstract][Full Text] [Related]
17. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
[TBL] [Abstract][Full Text] [Related]
18. Discrepancy between results of randomized control studies and retrospective analysis: the case of statin therapy effect on one-year mortality in patients with decompensated heart failure.
Nevzorov R; Novack V; Henkin Y; Kobal SL; Jotkowitz A; Porath A
Eur J Intern Med; 2009 Sep; 20(5):494-8. PubMed ID: 19712852
[TBL] [Abstract][Full Text] [Related]
19. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.
Tagalakis V; Eberg M; Kahn S; Azoulay L
Thromb Haemost; 2016 Jun; 115(6):1220-8. PubMed ID: 26819144
[TBL] [Abstract][Full Text] [Related]
20. Venous Thromboembolism in Primary Nephrotic Syndrome - Is the Risk High Enough to Justify Prophylactic Anticoagulation?
Rankin AJ; McQuarrie EP; Fox JG; Geddes CC; MacKinnon B;
Nephron; 2017; 135(1):39-45. PubMed ID: 27669572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
